Global Anticoagulant Registry in the Field "GARFIELD-AF"

Recruiting

Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

Prospective Cohort
- Written informed consent
- Age 18 years and older
- New diagnosis of non-valvular atrial fibrillation (diagnosed within the last 6 weeks) with at least one additional risk factor for stroke and regardless of therapy.
Retrospective validation cohort
- Written informed consent
- Age 18 years and older
- Diagnosis of non-valvular AF (diagnosed 6-24 months prior to enrolment) with at least one additional risk factor for stroke and regardless of therapy.
Exclusion criteria:
- No further follow-up envisaged or possible within enrolling hospital or with associated family practitioner.
- Patients with transient AF secondary to a reversible cause.
- Patients recruited in controlled clinical trials.